Patients with advanced cancers often contemplate the time burden of their cancer care. What does this exactly entail? Dr Arjun Gupta, an Oncologist and Researcher, recently wrote a paper about Time Toxicity for Cancer patients. He helps us understand this new concept and how it can affect quality of life for patients.
What is ‘’time toxicity’’?
We have seen tremendous progress in oncology in the past few decades. Yet, for advanced solid cancers, average survival benefits offered by new…
The U.S. Food and Drug Administration approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer. Cologuard offers people 50 and older at average risk for colorectal cancer an easy-to-use screening test they can do in the privacy of their own home.
Colorectal cancer was the third most common cancer with nearly 1.4 million new cases in 2012.
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm409021.htm
Community
Condition
Changed
Fri, 09/12/2014 - 15:09
